推荐应用
Siglec-2, also known as B-cell antigen CD22 or B-lymphocyte cell adhesion molecule (BL-CAM), is a B-cell restricted glycoprotein that is expressed in the cytoplasm of progenitor B and pre-B cells and on the surface of mature B cells. The predominant Siglec-2/CD22 beta encodes an 847 amino acid (aa) polypeptide with a hydrophobic signal peptide, an N-terminal Ig-like V-type domain, six Ig-like C2-type domains, a transmembrane region and a cytoplasmic tail with 4 immunoreceptor tyrosine-based inhibition motifs (ITIMs). Siglec-2/CD22 is a coreceptor that physically interacts with B-cell receptor (BCR) and is rapidly phosphorylated upon BCR ligation. It negatively regulates BCR signals by recruiting tyrosine phosphatase SHP-1 to its ITIMs. Phosphorylated Siglec-2/CD22 can also interact with other intracellular effector proteins such as Syk, PLC gamma, PI3 kinase and Grb-2, suggesting it may play a role in positive signaling.
高纯度、高活性、低内毒素、高批间一致性

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
1215
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
1336
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
755
2026-04-22
【应用方向】TNFR蛋白家族概述
750
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
843
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
669
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
665
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
679
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
610
2026-04-20
【技术讲解】ADC药物研究相关靶点汇总
19112
2025-07-30
【应用方向】抗体药筛选的关键—靶点蛋白
11138
2025-07-09
【技术讲解】重要免疫检查点:PD-1及其配体
20445
2025-07-24
【应用方向】药靶明星|FGFs&FGFRs家族蛋白解析
18705
2025-07-24
【应用方向】热门肿瘤靶点蛋白-EGFR表皮生长因子受体
6539
2025-07-24
【技术讲解】双抗热门靶点-双特异性抗体靶点CD3D&CD3E
14922
2022-09-05





